MyOme Launches Integrated Polygenic Risk Score for Prostate Cancer
The whole-genome test combines data from 7 million genetic markers with clinical risk factors to provide individualized 10-year and lifetime risk assessments.
Latest Articles
Editor's Top Picks
FDA Clears Automated Platform for Multiple Myeloma Diagnosis
The system combines enhanced sensitivity with automation to detect M-proteins at low concentrations, supporting early diagnosis of plasma cell disorders.
Be the First to Know What’s Next in the Lab
Every week, we dig into the biggest shifts, breakthroughs, and tech transforming clinical diagnostics. Straightforward, insightful, and always relevant.Critical Resources
Diagnostic Innovations
Optical Genome Mapping Detects Hidden Genetic Causes of Pregnancy Loss
Two studies show the advanced technique can identify chromosomal abnormalities missed by traditional genetic testing methods.
Equipment & Supply Spotlight
Security Vulnerabilities Found in Portable DNA Sequencers
Researchers identify critical flaws in Oxford Nanopore devices that could expose or alter genetic data without detection.
News, Know-How & Standards
Disease Detection & Understanding
BD HPV Assay Receives WHO Prequalification for Global Cervical Cancer Screening
The BD Onclarity HPV Assay detects 14 high-risk HPV types and supports self-collection.
